Association of Apical Periodontitis With Hs-CRP and Hemogram Indices
Launched by POSTGRADUATE INSTITUTE OF DENTAL SCIENCES ROHTAK · Jul 19, 2021
Trial Information
Current as of July 21, 2025
Unknown status
Keywords
ClinConnect Summary
Prevalence of Apical periodontitis (AP) is reported in the range of 17% to 65% with higher prevalence reported in older patients. Infection of the pulp tissue of the affected tooth is the principal cause of apical periodontitis and it is characterised by inflammation of the periradicular tissues. Presentation of AP varies from classical signs of inflammation (pain, swelling, loss of function) to being completely asymptomatic with only signs of apical bone resorption on the radiograph. Histological changes seen in AP is localized infiltration of inflammatory cells and bone resorptions. AP ca...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Pulpal necrosis in mature mandibular molar as confirmed by negative response to pulp sensibility test (cold and electric pulp test)
- • Radiographic evidence of apical periodontitis in the form of periapical radiolucency
- • Radiographic alveolar bone breakdown not more than one third of root length.
- Exclusion Criteria:
- • Obese (BMI \>30 kg/m2), smoker, pregnant, diabetic, immunocompromised or have any other systemic inflammatory condition.
- • Having a positive history of antibiotic use within the past month or require antibiotic premedication for dental treatment (including infective endocarditis or prosthetic joint prophylaxis).
- • Teeth having previous root fillings, unrestorable teeth, fractured/perforated roots, grade 3 mobility, and history of recent periodontal therapy (within previous 6 months).
- • Teeth with established endodontic-periodontal lesions exhibiting \<2 mm radiopaque bone between the root apex.
About Postgraduate Institute Of Dental Sciences Rohtak
The Postgraduate Institute of Dental Sciences, Rohtak, is a premier academic institution dedicated to advancing dental education, research, and clinical practice. With a commitment to fostering innovation in oral health, the institute is actively engaged in conducting clinical trials that aim to enhance treatment methodologies and improve patient outcomes. By integrating cutting-edge research with comprehensive training, the institute plays a pivotal role in shaping the future of dental sciences, while adhering to the highest ethical standards and regulatory guidelines in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rohtak, Haryana, India
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials